BioVie Inc. Other Non-Current Liabilities
BioVie Inc. (BIVI) had Other Non-Current Liabilities of $48.38 thousand as of 2022-06-30, per its 10-K filed 2023-08-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2023-08-16
- 2022-06-30: Other Liabilities, Noncurrent $48.38K.
- 2022-03-31: Other Liabilities, Noncurrent $193.54K.
- 2021-12-31: Other Liabilities, Noncurrent $338.70K.
- 2021-09-30: Other Liabilities, Noncurrent $483.85K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2022-06-30 | $48.38K 10-K · filed 2023-08-16 |
| 2022-03-31 | $193.54K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $338.70K 10-Q · filed 2022-02-08 |
| 2021-09-30 | $483.85K 10-Q · filed 2021-11-10 |
| 2017-03-31 | $575.92K 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |